Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms. [PDF]
Gall-Ianotto CL +8 more
europepmc +1 more source
CHEK2 Germline Variants in Early‐Onset and Familial Myeloproliferative Neoplasms [PDF]
Oscar Borsani +8 more
openalex +1 more source
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms. [PDF]
Pesini C +23 more
europepmc +1 more source
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia [PDF]
Bing Li, Robert Peter Gale, Zhijian Xiao
core +1 more source
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms. [PDF]
Davidsen ID +13 more
europepmc +1 more source
Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms. [PDF]
Costa A, Breccia M.
europepmc +1 more source
Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms. [PDF]
Christen M +13 more
europepmc +1 more source
Non-invasive detection of bone marrow fibrosis in myeloproliferative neoplasms using cell-free RNA. [PDF]
Saad M +10 more
europepmc +1 more source
Protein profile in chronic myeloproliferative neoplasms (MPN)
Miguel Gallardo +12 more
openalex +1 more source

